The ALP (alkyl-lysophospholipid) edelfosine (1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine) induces apoptosis in S49 mouse lymphoma cells. A variant cell line, S49 AR , made resistant to ALP, was found previously to be impaired in ALP uptake via lipid-raft-mediated endocytosis. In the present paper, we report that these cells display cross-resistance to Fas/CD95 ligation [FasL (Fas ligand)], and can be gradually resensitized by prolonged culturing in the absence of ALP. Fas and ALP activate distinct apoptotic pathways, since ALP-induced apoptosis was not abrogated by dominant-negative FADD (Fas-associated protein with death domain), cFLIP L [cellular FLICE (FADD-like interleukin 1β-converting enzyme)-inhibitory protein long form] or the caspase 8 inhibitor Z-IETD-FMK (benzyloxycarbonyl-IleGlu-Thr-Asp-fluoromethylketone). ALP-resistant cells showed decreased Fas expression, at both the mRNA and protein levels, in a proteasome-dependent fashion. The proteasome inhibitor MG132 partially restored Fas expression and resensitized the cells to FasL, but not to ALP. Resistant cells completely lacked SM (sphingomyelin) synthesis, which seems to be a unique feature of the S49 cell system, having very low SM levels in parental cells. Lack of SM synthesis did not affect cell growth in serumcontaining medium, but retarded growth under serum-free (SMfree) conditions. SM deficiency determined in part the resistance to ALP and FasL. Exogenous short-chain (C 12 -) SM partially restored cell-surface expression of Fas in lipid rafts and FasL sensitivity, but did not affect Fas mRNA levels or ALP sensitivity. We conclude that the acquired resistance of S49 cells to ALP is associated with down-regulated SM synthesis and Fas gene transcription and that SM in lipid rafts stabilizes Fas expression at the cell surface.
INTRODUCTION
Synthetic alkylphospholipids such as edelfosine [1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine; also known as alkyllysophospholipid (ALP)] and perifosine (D-21266) selectively induce apoptosis in tumour cells [1] [2] [3] , have anti-angiogenic properties [4] , are enhancers of radiation-induced apoptosis [1, 3, [5] [6] [7] and are currently being tested as novel anticancer agents in clinical trials [1, 7] . These single-chain alkylphospholipids accumulate in cell membranes [8] , resist cellular lipases and interfere with lipid-based signal transduction [1, 3, 9] and phospholipid biosynthesis, as we have studied previously in S49 mouse lymphoma cells [10, 11] . A variant cell line, S49 AR , made resistant to ALP, showed impaired uptake of this compound, as well as other alkylphospholipids, by lipid-raft-mediated endocytosis [10] [11] [12] . Interestingly, these S49 AR cells lacked the biosynthesis of the raft constituent SM (sphingomyelin) because of complete down-regulation of SMS1 (SM synthase 1) [13] . We furthermore demonstrated that the down-regulation of SMS1 in parental S49 cells by siRNA (short interfering RNA) evoked cellular resistance to multiple structurally related alkylphospholipids [11] . This SM deficiency and impaired raftdependent uptake associated with alkylphospholipid resistance was specific for lymphoma cells, since carcinoma cells made resistant to these compounds showed normal SM synthesis/levels and displayed a different uptake mechanism [12] .
Two mammalian SMS isotypes exist: SMS1 residing in the trans-Golgi network, and SMS2 located both at the Golgi and the plasma membrane [14, 15] . Only the former isotype is expressed in the S49 lymphoma system used in the present study [13] . SMS1 and its two enzymatic products, SM and diacylglycerol, play a major role in membrane microdomain (lipid raft) formation and vesicle biogenesis at the trans-Golgi network respectively [14, 16] . Diacylglycerol recruits and co-activates protein kinase D [17] , which is required for efficient formation of Golgiderived secretory vesicles [16] . This SMS1/protein kinase Dmediated process is critical for transport of proteins from the trans-Golgi network to the plasma membrane. Cells that lack SMS1 (and SMS2) activity reportedly have a severe growth defect [15, 18, 19] .
Since SMS1-deficient S49 AR cells have a defect in raftmediated endocytosis of ALP [10, 13] , and since lipid rafts have been implicated in apoptosis induction via the death receptor Fas/CD95/APO-1 (apoptosis antigen 1) [20] [21] [22] [23] [24] [25] , we questioned whether the SMS1/raft defect in the S49 AR cells could have consequences for the sensitivity of these cells to Fas ligation. The interaction between Fas and its ligand (FasL) triggers receptor oligomerization in lipid rafts at the plasma membrane, death-domain-mediated recruitment of the adaptor protein FADD (Fas-associated protein with death domain), and binding and activation of pro-caspase 8 and/or 10 to FADD through their death-effector domains in a DISC (death-inducing signalling complex) [26] . Complete DISC assembly requires Fas to move into endosomal compartments [26, 27] , initiating further a caspase cascade responsible for the apoptotic process. In certain cells (type II cells; see the Discussion), ALP was found to trigger Fas signalling independently of ligation [22, 28, 29] .
In the present paper, we report that, in S49 cells, ALP induces apoptosis independently of the Fas receptor, and that the ALPresistant S49 AR cells are cross-resistant to Fas ligation. We find that the lack of SM synthesis in these resistant cells retarded cell growth under serum-free conditions and is associated with reduced proteasome-dependent Fas mRNA and protein levels.
EXPERIMENTAL

Materials
ALP was purchased from BioMol. [ 3 H]ALP (58 Ci/mmol) was synthesized by Moravek Biochemicals. [methyl- 14 C]Choline chloride (58 mCi/mmol) and L- [3- 14 C]serine (54 mCi/mmol) were from GE Healthcare. [ 3 H]1-Sphingosine was synthesized by Piet Weber (DSM, Delft, The Netherlands). C 12 -SM (lauroyl-SM) was from Avanti Polar Lipids. Tween 20 and Silica 60 TLC plates were from Merck. Anti-Fas mAb (monoclonal antibody) 7C10 was from Campro Scientific. Anti-Fas mAb Jo2 (hamster IgG2) and its FITC conjugate, as well as FITC-conjugated anti-CD90/Thy-1.1 mAb were from BD Biosciences Pharmingen. Rabbit anti-β-actin was from Cell Signaling Technology. Rabbit anti-mouse immunoglobulin conjugated to HRP (horseradish peroxidase) and swine anti-(rabbit Ig)-HRP were from Dako. Protein G-Sepharose Fast Flow beads were from GE Healthcare. Soluble recombinant human FasL was from Alexis. Z-IETD-FMK (benzyloxycarbonyl-Ile-Glu-Thr-Asp-fluoromethylketone) was from Calbiochem. MG132, lactacysteine and MβCD (methyl-β-cyclodextrin) were from Sigma.
Cells and culture conditions
Mouse S49.1 lymphoma cells (S49) were cultivated in Dulbecco's modified Eagle's medium (Gibco/Invitrogen), containing high levels of glucose and pyruvate, supplemented with 8 % fetal calf serum, 2 mM L-glutamine and antibiotics. ALP-resistant variants (S49 AR ) were isolated in two selection rounds of growth in 15 μM ALP for 72 h, followed by plating in semi-solid medium and isolation of colonies of surviving cells [30] . S49 AR cells could be grown continuously in 15 μM ALP. All experiments with S49 AR cells were performed with cells grown without the selection agent for at least 1 week. Loading of S49 AR cells with exogenous C 12 -SM was performed by injecting the ethanol-dissolved lipid into the complete culture medium (final concentration 20 μM C 12 -SM; 0.02 % ethanol) and culturing the cells in this medium for 3 days. To estimate the growth rate in the absence of (exogenous) SM, cells were grown in a serum-free medium [31] .
Plasmids, quantitative PCR and RNA interference
Human FADDdn (dominant-negative FADD), lacking amino acids 2-77, and mouse cFLIP L [cellular FLICE (FADD-like interleukin 1β-converting enzyme)-inhibitory protein long form] were cloned into the retroviral vector LZRS-MS-IRES-eGFP as described by Werner et al. [32] . Transduced cells were selected for eGFP (enhanced green fluorescent protein) expression using a MoFlo high speed cell sorter (Cytomation). For quantitative PCR, for Fas/CD95 we used the forward primer 5 -GCGATTCTCCTGGCTGTGAA-3 , and the reverse primer 5 -CACGGCTCAAGGGTTCCAT-3 . The amplification was related to GAPDH (glyceraldehyde-3-phosphate dehydrogenase), using the forward primer 5 -TGCACCACCAACTGCTTAG-3 , and the reverse primer 5 -GGATGCAGGGATGATGTTC-3 .
SMS1 was down-regulated in S49 cells by retroviral transduction of siRNAs, yielding S49 siSMS1 cells, as published previously [13] . Control cells (S49 mock ) were transduced with scrambled siRNA [13] . Retroviral transduction of HA (haemagglutinin)-tagged SMS1 in S49 AR cells, yielding AR-SMS1 cells, was carried out after cloning SMS1 (from S49 cDNA) in the pBabe vector, using forward primer 5 -GATCGGATCCTA-CGATGTTCCAGATTACGCGATGTTGTCTGCCAGGACCA-TGAAGG-3 and reverse primer 5 -GAATTCTTATGTGTCG-TTTACCAGCCG-3 .
Immunoblotting and immunoprecipitation
S49 cells were washed once with PBS and lysed in lysis buffer [10 mM Tris/HCl (pH 7.8), 150 mM NaCl, 5 mM EDTA, 1 % (v/v) Nonidet P40, protease inhibitor cocktail (Roche), 1 mM sodium vanadate and 20 mM NaF). Lysates were incubated for 30 min at 4
• C and spun at 12000 g for 20 min to remove cellular debris, before being normalized for protein content. Before Western blot analysis, samples were heated for 10 min at 70
• C in reducing SDS sample buffer from Invitrogen Life Technologies containing 1 mM DTT (dithiothreitol) and run on a Novex mini-gel in NuPage Mes/SDS running buffer (Invitrogen Life Technologies). Separated proteins were transferred on to nitrocellulose membranes and blocked with 3 % (w/v) BSA for 1 h in TBS-T [Tris-buffered saline with Tween 20: 10 mM Tris/HCl (pH 7.5), 150 mM NaCl and 0.05 % Tween 20] containing a 1:50 dilution of Roche Blocking Reagent. Blots were incubated overnight at 4
• C with 7C10 mAb (1:1000 dilution), followed by incubation with HRP-conjugated rabbit anti-(rat Ig) antibody Ig (1:2000 dilution), and immunoreactive proteins were visualized by ECL (enhanced chemiluminescence).
For immunoprecipitation experiments, equal protein contents from pooled raft fractions (fractions 3-5) and non-raft fractions (fractions 8-10) from S49, S49 AR , S49 mock or S49 siSMS1 cells [11, 13] were added to a final volume of 500 μl of lysis buffer. Anti-Jo2 mAb was added to the samples which were then incubated overnight at 4
• C with continuous rotation. Immune complexes were incubated with Protein G-Sepharose beads for an additional 1 h. Precipitated proteins were washed three times with immunoprecipitation washing buffer [50 mM Tris/HCl (pH 7.5), 5 mM EDTA, 150 mM NaCl and 0.1 % Tween 20]. Samples were subjected to gel electrophoresis for immunoblotting as described above.
Confocal microscopy and flow cytometry
Cells were seeded on to RetroNectin-coated coverslips, washed three times with PBS and fixed in 4 % (v/v) formaldehyde for 30 min. Cells were washed with PBS, blocked in TBS-T containing 1 % BSA, washed five times in TBS-T, incubated with anti-Jo2 mAb, washed three times with TBS-T and then incubated with FITC-anti-hamster antibody. Coverslips were mounted in Vectashield (Vector Laboratories) and viewed under a Leica TCS NT confocal laser-scanning microscope. For flow cytometry, cells were washed three times with 0.5 % BSA in PBS containing 0.01 % sodium azide. Cells were incubated with FITCconjugated Jo2 mAb, or with FITC-anti-CD90/Thy-1.1 mAb. FACScan analysis was performed using FCS express 2.0.
Apoptosis assay
Cells were seeded at 10 6 cells/ml, cultured overnight and incubated for indicated time periods with various concentrations of ALP or FasL. Cells were stained with propidium iodide, and the percentage of sub-diploid apoptotic nuclei was determined using a FACScan instrument (Becton Dickinson) [10, 33] .
Lipid analysis
Cells at 10 6 cells/ml were labelled with [methyl-
At the time points indicated, aliquots of cells were taken, washed and resuspended in 200 μl of PBS. Lipids were extracted with chloroform/methanol (1:2, v/v) and phase separation was induced using 1 M NaCl. The organic phase was washed in methanol/water/chloroform (47:49:3, by vol.), and separated by silica TLC, using chloroform/methanol/acetic acid/water (60:30:8:5, by vol.) or, in the case of sphingosine labelling, using chloroform/methanol/0.2 % CaCl 2 (60:40:9, by vol.). Radioactive lipids were visualized and quantified using a Fuji BAS 2000 TR PhosphoImager and identified using iodinestained standards. Tritiated lipids were visualized after dipping the TLC plate in 12.5 % diphenyloxazole dissolved in diethyl ether, drying and subsequent autoradiography. Unlabelled lipids (e.g. C 12 -SM) were visualized by spraying the plate with sulfuric acid, followed by heating (charring) in an oven at 180
• C for 30 min, and (semi-)quantified by densitometry.
Mass sphingolipid analyses were conducted by liquid chromatography and electrospray ionization tandem MS as described by Merrill et al. [34] .
Isolation of lipid rafts
A lipid raft fraction was prepared by detergent extraction of cells and sucrose gradient centrifugation [10] . Briefly, 2 × 10 8 cells were solubilized into 1 ml of ice-cold 25 mM Mes, 150 mM NaCl and 1 % (v/v) Triton X-100, homogenized using a Dounce homogenizer and fractionated on a discontinuous sucrose gradient at 39 000 rev./min in a SW41 rotor (Beckman Coulter) for 20 h at 4
• C.
Statistical analysis
Results are expressed as means + − S.D. Mean values were compared using Student's t test. Significant differences are expressed as *P < 0.01 and **P < 0.001.
RESULTS
S49 lymphoma cells made resistant to ALP (S49 AR cells) are cross-resistant to Fas-induced apoptosis; ALP does not initiate Fas signalling
Previously, we reported that a synthetic ALP (edelfosine) induces apoptosis in S49 lymphoma cells, in a dose-and timedependent fashion [10, 12] . The onset of apoptosis was already apparent after 3 h (see Supplementary Figure S1 at http://www. BiochemJ.org/bj/425/bj4250225add.htm). In the present study, we used 15 μM ALP for 6 h to induce 50-90 % apoptosis (variation among different experiments) in these cells. An ALPresistant variant cell line, S49 AR , was generated by culturing S49 cells in the presence of this ether-lipid and repeated selection of surviving cells [10, 30] . Figure 1 (A) shows that these ALPresistant S49 AR cells were also largely resistant to Fas-induced apoptosis, whereas the parental S49 cells underwent apoptosis when exposed to ALP as well as by Fas ligation.
To explain this cross-resistance of S49 AR cells to ALP and FasL, we tested the obvious possibility that the two apoptotic stimuli would initiate the same signalling pathway, i.e. via the Fas receptor, as has been suggested for HL-60 and Jurkat Tcells [28, 29] . Fas signalling depends on recruitment of the Fas adapter protein FADD and on recruitment and activation of caspase 8, whereas this process is inhibited by cFLIP L [26, 32, 35] . We therefore retrovirally transduced S49 cells with FADDdn or with cFLIP L (transduced cells were sorted on the basis of eGFP expression) and found that the resulting S49
FADDdn and S49 FLIP cells were fully resistant to FasL, but not to ALP ( Figures 1B and 1D ). The same was true for S49 cells that were treated with the caspase-8-specific inhibitor Z-IETD-FMK [26, 27] (Figure 1D ). In addition, we tested the combination of (suboptimal doses of) ALP and FasL together, which gave, at most, an additive, but no synergistic, effect on apoptosis, whereas FADDdn in this case reduced apoptosis to the level induced by ALP alone ( Figure 1B ). These data indicate that, in S49 cells, ALP does not induce apoptosis via the Fas pathway, and neither is there cross-talk between ALP-and FasL-induced apoptotic signalling. In agreement with this notion, ALP-and FasL-induced apoptosis were differentially sensitive to the lipidraft-disrupting agent MβCD (which extracts cholesterol from rafts) ( Figure 1C ). MβCD did not affect FasL-induced apoptosis in S49 cells, but inhibited ALP-induced apoptosis in these cells, as we reported previously [10, 11] .
From these collective data, we conclude that ALP does not activate the Fas signalling pathway. Thus the cross-resistance of S49 AR cells to ALP and FasL has to be explained by a mechanism that differs from a common defect in Fas signalling.
Apoptosis-resistant S49
AR cells show SM deficiency as a result of down-regulated SMS1; effect on cell proliferation
We reported previously that the ALP-resistance of S49 AR cells was accompanied by a lack of SM synthesis (see Supplementary Fig ure S2 at http://www.BiochemJ.org/bj/425/bj4250225add.htm) as a result of an almost complete down-regulation of SMS1 expression, whereas SMS2 is not present at all [13] . To investigate a possible causal relationship between SMS1/SM deficiency and the resistance of S49 AR cells to Fas ligation, we first excluded the possible involvement of secondary changes in lipid synthesis/composition. The S49 AR cells displayed no altered rates of biosynthesis of lipids other than SM (see Supplementary Figure S2 ). We next measured the mass levels of individual species of sphingolipids in S49 and S49 AR cells and we determined how SMS1 knockdown by siRNA, yielding S49 siSMS1 cells [13] , would affect the mass levels of SM and its metabolic precursor ceramide (commonly associated with apoptosis). We also measured GlcCer (glucosylceramide), a precursor for the more complex glycolipids. Figure 2(A) shows the palmitoyl (C 16:0 ) species to be the most prominent cellular SM and GlcCer. Ceramide contained, in addition, substantial amounts of other acyl species (C 16 -dihydroceramide, C 24:0 and C 24:1 ). Although S49 AR cells completely lack SMS activity, they still contained 20 % SM relative to S49 cells. S49 siSMS1 cells even contained 40 % of the SM content of S49 cells. Clearly, these SM molecules in SMS1-deficient cells were mostly derived from the serum in the culture medium (compare the two upper panels in Figure 2A ). The contents and compositions of ceramide and GlcCer showed no significant differences between the three cell types.
In the light of several reports suggesting that SM synthesis would be essential for cell growth [15, 18, 19] , we compared the growth of S49 AR cells with that of S49 cells. We found that, in serum-containing medium, SMS-deficient S49 AR cells have almost the same growth rate as the parental S49 cells. However, in serum-free (SM-free) conditioned medium [31] , S49 cells grew more slowly and growth of S49 AR cells was even more retarded, particularly after 2 days ( Figure 2B ), but were not completely growth arrested.
The data thus suggest that SM is the only sphingolipid downregulated in the S49 AR and S49 siSMS1 cells, and that SMS1 AR cells in serum-containing and serum-(SM-) free medium [31] . The number of cells were counted during 3-4 consecutive days.
deficiency does not substantially affect the (mass) levels of ceramide or GlcCer, so that these lipids are not likely to be related to the mechanism of apoptosis resistance. Furthermore, we find growth retardation (but not complete arrest) of cells that are SMS-deficient, but only if the culture medium is deprived of SM as well. 
Deficient SM synthesis is not the sole cause of resistance to apoptosis induction
We demonstrated previously that S49 AR cells are resistant to ALP because, in contrast with S49 cells, they are unable to internalize ALP via their SM-deficient lipid rafts [10, 11, 13] . Figure 3 illustrates that in S49 siSMS1 cells, in which SMS1 is downregulated [13] , SM synthesis is barely visible and ALP-induced apoptosis is decreased from 55 % to 15 %, whereas S49 AR cells are completely devoid of SM synthesis and completely resistant to ALP. Intriguingly, we find that, together with SMS1 downregulation, FasL-induced apoptosis also fell from 54 to 28 % in S49 siSMS1 cells, and to 14 % in S49 AR cells ( Figure 3B ). Although apoptosis resistance was induced by prolonged culturing of S49 cells in the continuous presence of ALP, we found that when the resistant S49 AR cells were cultured in the absence of ALP for more than 4 weeks, they gradually lost their resistance (yielding resensitized S49 ARS cells) and, strikingly, regained SM synthesis ( Figure 3C ). This finding would argue against a possible 'clone' effect of S49 AR cells, rather suggesting a reversible selection pressure of ALP. So far, we conclude that SM deficiency in S49 AR and S49 siSMS1 cells and SM reappearance in S49 ARS cells closely correlate with cross-resistance/resensitization to ALP-and FasL-induced apoptosis.
To confirm the causal link between SM synthesis and the sensitivity to ALP and FasL, we reintroduced SMS1 into S49 AR cells by retroviral transduction of HA-tagged SMS1, yielding cells designated AR-SMS1. HA-SMS1 was properly expressed (Western blot in Figure 3B ) and active (appearance of SM spot on TLC; Figure 3A , right-hand panel), and the SM produced was recovered in the detergent-resistant membrane (lipid raft) fraction, as in the S49 parental cells (see Supplementary Figure  S3 at http://www.BiochemJ.org/bj/425/bj4250225add.htm). Yet, these cells failed to undergo apoptosis by ALP or FasL ( Figure 3B ). So, by simple reappearance of SM, the cells did not regain their original (S49-like) ALP-sensitive phenotype. This negative result excludes SMS1 as a direct and sole determinant of apoptosis sensitivity. The apparent discrepancy with the S49 siSMS1 data can be explained by proposing the causal involvement of yet another (additional) unknown factor/protein, the expression of which is modulated concomitantly with down-regulated SMS1 in S49 AR and S49 siSMS1 cells. Thus, unlike our earlier suggestion [13] , SMS1 deficiency is not the sole determinant of the apoptosis resistance.
Fas is down-regulated in ALP-resistant S49
AR and S49 siSMS1 cells
Both SM and the Fas receptor are located in lipid raft domains at the cell surface [14, [20] [21] [22] [23] [24] [25] . The first step in Fas signalling is ligand-induced formation of Fas microaggregates at the cell surface [26] . We therefore compared the surface expression of Fas in the FasL-resistant SM-deficient S49 AR and S49 siSMS1 cells with the FasL-sensitive S49 cells. Confocal microscopic images revealed that the expression of Fas ( Figure 4A ) at the cell surface was significantly reduced in S49 siSMS1 cells and, even more so, in S49 AR cells. Figure 4 (B) shows a quantification of this reduced Fas surface expression, as determined by FACS analysis.
Since Fas is often localized in lipid raft domains, even before stimulation [20, 21, 24 ,25], we measured Fas in detergent-resistant lipid raft fractions from FasL-sensitive and -resistant cells. It was already apparent in immunoblots of the total lysates of these cells, that Fas expression was much reduced in S49 siSMS1 cells and almost undetectable in S49 AR cells ( Figure 4C ). Lipid raft fractions (with SM as a marker) were isolated and pooled as shown in Supplementary Figure S3 . In the FasLsensitive S49 and S49 mock cells, Fas was immunoprecipitable from the combined lipid raft fractions, but not from the non-raft fractions ( Figure 4D ). Furthermore, Fas expression was low in or virtually absent from raft fractions from FasL-resistant S49 siSMS1 and S49 AR cells respectively. Reduced cell-surface expression seemed specific for Fas, since expression of other receptors, such as the transferrin receptor [10] and raft-localized Thy-1 (a glycosylphosphatidylinositol-linked protein) ( Figure 4B , lower panel), were not decreased in the resistant cells.
We next compared the Fas mRNA levels of S49 siSMS1 and S49 AR cells with those of the parental S49 cells, using quantitative PCR. Figure 5 (A) shows that these levels are dramatically decreased in the resistant cell. Artificial loading of cells with short-chain (C 12 -) SM (see below) had no effect, so that Fas mRNA expression is not regulated by SM content. 
SM stabilizes Fas expression at the cell surface
We questioned whether SM would determine Fas expression at the cell surface and we therefore reconstituted S49 AR cells with exogenous SM. However, substantial loading of the plasma membrane with exogenous natural SM (a rigid molecule with two long hydrophobic chains) is notoriously difficult, and, eventually, we were only successful when we pre-loaded the serum in the culture medium with the less hydrophobic shorter-chain C 12 -SM, as published and discussed previously [13] . Upon subsequent cell culturing, sufficient C 12 -SM was incorporated in cell membranes ( Figure 5A, inset) , and also in the lipid raft fractions [13] , to an estimated amount of 500 pmol/10 6 cells (i.e. 3-fold higher than endogenous SM in S49 cells). This SM loading of S49 AR cells enhanced the cell-surface expression of Fas significantly and consistently, although not to the high levels found in the S49 cells ( Figure 6A ). SM-loaded S49 AR cells became partly resensitized to FasL-induced apoptosis (dose-dependently), but notably not to apoptosis induction by ALP ( Figure 5B ). There was no change in the total Fas mRNA level ( Figure 5A ), and there was only a minor elevation of the total Fas protein level, but this elevation was amplified in the isolated lipid raft fraction ( Figure 5C ). Collectively, these data would suggest that SM promotes or stabilizes Fas localization in lipid rafts at the cell surface. Since SM apparently shifted Fas partitioning from the cell interior towards the cell surface without substantial changes in total Fas protein, it is conceivable that nascent Fas protein follows the same vesicular route as newly synthesized SM, which originates in the Golgi (where SMS1 resides [15] ) and ends up in the outer leaflet of the plasma membrane lipid bilayer [14] [15] [16] 36] . To support this idea, we treated the cells with brefeldin A, commonly employed to induce an in vivo collapse of the cis/medial Golgi on to the endoplasmic reticulum [37] , and known to prevent SM vesicular trafficking to the plasma membrane [38] . Figure 6(C) shows the rate of SM synthesis, using [ 14 C]choline as a precursor, and the effect of brefeldin A. Similar results were obtained with [
14 C]serine as a SM precursor (not shown). Figure 6 (C) (right-hand panel) confirms that newly synthesized SM indeed ends up in the outer plasma membrane leaflet, as it is accessible/hydrolysable by exogenous (bacterial) sphingomyelinase. Figure 6 (C) (middle panel) shows that brefeldin A precludes SM synthesis in the S49 cell system, whereas Figure 6 (B) shows that such SM deprivation of the plasma membrane is associated with a decreased expression of Fas at the cell surface. Brefeldin A had no effect on the very low Fas surface expression in S49 AR cells (results not shown). The inhibitory effect of brefeldin A on FasL-induced apoptosis in S49 cells was approx. 30 % (after subtracting some background apoptosis; results not shown).
We conclude that SMS1 deficiency in the ALP-resistant S49 siSMS1 and S49 AR cells is associated with down-regulated Fas/CD95, at both the mRNA and protein levels. In ALP-sensitive S49 cells, the SMS1 product SM, while undergoing vesicular transport to the cell surface, may (co-)determine (stabilize) Fas partitioning at the cell surface. Failure to do so may to some extent (but not fully) explain cellular resistance to FasL-induced apoptosis.
Fas down-regulation is proteasome-dependent
We searched further for the mechanism by which Fas was downregulated in ALP-resistant cells. Since SM stabilized Fas at the cell surface, we considered the possibility that, in the absence of SM, Fas protein might be cleaved from the cell surface by matrix metalloproteinase(s) [36, 39] . However, a broad-spectrum inhibitor of these proteases, GM 6001 (from BIOMOL; up to 500 nM), had no effect on Fas surface expression or FasL-induced apoptosis (results not shown).
Since Fas has been found to be associated with proteins implicated in the ubiquitination pathway [36] , and proteasome inhibitors reportedly enhanced the expression of Fas in smooth muscle cells [40] , we added the well-known proteasome inhibitor MG132 and found a gradual restoration of Fas protein expression in S49
AR and S49 siSMS1 cells, in a 4 h time period ( Figure 7A ). Similar results were obtained with another proteasome inhibitor, lactacysteine (5 μM) (not shown). Proteasome inhibition also enhanced Fas mRNA levels (approx. 5-fold), in both resistant and sensitive cells (results not shown), but did not affect the prominent Fas protein expression in parental S49 or in S49 mock cells ( Figure 7A ), indicating that that proteasomal regulation of Fas expression is particularly apparent in resistant SMS1-deficient cells. We found no effect of MG132 on SM synthesis in S49 cells, or on the lack of SM synthesis in S49 AR or S49 siSMS1 cells (results not shown). We found no evidence for Fas ubiquitination (using anti-ubiquitin antibodies).
We next tested whether MG132-induced recovery of Fas could restore FasL-sensitivity in the S49 AR and S49 siSMS1 cells. Cells were pre-incubated with MG132 for various times (up to 3 h) and then stimulated with FasL or ALP (for comparison). Figure 7(B) shows that, indeed, FasL-induced apoptosis in these MG132-treated SMS1-deficient cells was increased time-dependently, whereas MG132 by itself did not induce apoptosis and neither did it restore ALP-induced apoptosis in these cells. MG132 thus selectively enhanced FasL-induced apoptosis, in agreement with the enhanced Fas expression ( Figure 7A ).
In conclusion, continuous culturing of S49 cells in the presence of ALP causes resistance to ALP as well as FasL. The resistance to FasL, but not to ALP, is to a large extent due to enhanced proteasome-dependent degradation of (an) unknown factor(s) that determine(s) Fas transcription. The observation that the resistance to ALP was not reversed by the proteasome inhibitor is in line with our earlier conclusion that ALP-induced apoptosis does not proceed via the Fas receptor.
DISCUSSION
In the present study, we have shown that S49 lymphoma cells that have acquired resistance to ALP and related anti-tumour alkylphospholipids (S49 AR cells) are cross-resistant to FasLinduced apoptosis. We excluded the possibility that the crossresistance might be due to a common defect in Fas-mediated death signalling, since ALP induced S49 apoptotic death independently of Fas engagement; unlike Fas signalling, ALP-induced apoptosis was not dependent on FADD, not inhibited by cFLIP L or the caspase-8 inhibitor Z-IETD-FMK, and was blocked by MβCD sequestration of cholesterol. Furthermore, the proteasome inhibitor MG132 alleviated the resistance to Fas ligation, but not to ALP. Our conclusion that ALP induces apoptosis independently of Fas does not agree with reports by Mollinedo's group [2, 22, 28] , who showed ALP-induced clustering/redistribution of Fas into lipid rafts. However, this discrepancy can be explained by the different cell types used. In so-called type I cells (such as JY, HuT78, SKW6, H9), Fas is located in lipid rafts [21, 25] and DISC formation is fast and efficient, with high amounts of active caspase 8 formed, which activates directly the effector caspase 3. In type II cells (such as CEM, Jurkat or, multiple myeloma [2] ), Fas is largely located outside rafts and redistributes into rafts upon ligation [21, 25] , so DISC formation is delayed and insufficient to activate caspase 3 directly. For apoptosis induction, these type II cells need an amplification pathway via mitochondria, which can be inhibited by overexpression of Bcl-2 or Bcl-X L [41] . In S49 cells, these Bcl proteins do not block apoptosis induction by ALP [30] or FasL [42] , and Fas was found to be localized in lipid raft fractions ( Figure 4D) , consistent with the type I cell category. Accordingly and similar to other type I cells [21, 26] , we found no effect of cholesterol sequestration by MβCD on FasL-induced apoptosis in S49 cells ( Figure 1C) . Collectively, our present and previous data suggest that, in S49 lymphoma cells, ALP does not induce Fas signalling, but induces apoptosis mainly by its raft-mediated internalization and subsequent inhibition of phosphatidylcholine synthesis in the endoplasmic reticulum [1, 10, 11, 43] .
We reported that the apoptosis-resistance of S49 AR cells was associated with SMS1 down-regulation and consequent deficiency of the raft constituent SM. Such a lack of SM may impair (Fas-) receptor clustering in rafts and subsequent signalling, as was shown for the T-cell receptor in Jurkat cells [44] . Our reconstitution experiments with exogenous C 12 -SM in S49 AR cells revealed that SM can stabilize Fas expression in rafts at the cell surface. It is conceivable that SMS1 may deliver (endogenous) SM to nascent lipid rafts in Golgi vesicles [14, 15] , thus stabilizing newly made or recycling Fas in these microdomains. SMS1/SMdeficiency in S49 AR cells would then disable such stabilization of Fas, leading to its degradation or redirected intracellular location [36] . Our brefeldin A data support the idea that in the absence of SM synthesis and anterograde vesicular trafficking, Fas translocation to the cell surface is reduced. Similar observations have been reported for the nicotinic acetylcholine receptor [45] .
Lack of Fas stabilization, however, provides only part of the explanation of why these SM-deficient ALP-resistant cells are cross-resistant to FasL. S49 AR and S49 siSMS1 cells showed severely down-regulated expression of total Fas, largely already at the mRNA level. How SMS1 deficiency in these cells relates to decreased Fas mRNA remains unknown. The SMS1 product SM seems not to be involved in this Fas mRNA regulation, as loading of the SMS1-deficient cells with exogenous SM failed to enhance these mRNA levels. This artificial SM supplementation, however, elevated Fas exposure at the S49 AR cell surface, as discussed above, and hence increased FasL sensitization (despite the low levels of total Fas) ( Figures 5 and 6A ). Reduced Fas expression in SMS1-deficient cells was proteasome-dependent, because proteasome inhibitors (MG132 and lactacysteine) prevented this down-regulation. Proteasome inhibition has been reported previously to up-regulate molecules implicated in pro-apoptotic cascades, including a Fas-dependent pathway [36, 40] . However, proteasome involvement was not seen in Fas expressed in the SMS1-proficient S49 cells, nor in ALP (in)sensitivity. We ruled out the possibility that proteasome inhibition would restore SM synthesis in S49 AR cells (results not shown), so that other, as yet unknown, factor(s) regulating Fas expression are subject to proteasomal degradation in the resistant cells.
SMS1 down-regulation is not the only factor that determines the cellular cross-resistance to ALP and FasL. Although SMS1 siRNA-down-regulated cells (S49 siSMS1 ) were indeed resistant to both ALP and FasL, and long-term spontaneous resensitization (in the absence of ALP; S49 ARS cells) was accompanied by regained SM synthesis, re-expression of SMS1 in S49 AR cells by retroviral transduction failed to resensitize the cells to these apoptotic stimuli. We therefore conclude that the lack of SM synthesis in S49 AR cells is neither a 'clone' effect, nor is it (solely) responsible for the ALP and FasL resistance, but that other factor(s)/protein(s) are co-modulated together with SMS1 in the S49 AR and S49 siSMS1 cells that (co-)determine apoptosis sensitivity in these lymphoma cells. In this regard, we should also note that we found no reduced SM synthesis in other T-cells, such as Jurkat and CEM, that we made (partly) ALP-resistant (and also turned out to be partly cross-resistant to FasL) (results not shown). Our results might therefore be specific for the S49 cell system. The reason ALP resistance in S49 AR cells seems to be so uniquely associated with SM deficiency is not clear, but might be related to the fact that SM content in the parental S49 cells is already very low ( Figure 2A ) compared with other T-cells.
In the literature, there is no consensus on the possible role of SMS in apoptosis sensitivity. Although SMS1 alone did not determine apoptosis sensitivity in our S49 cell system, overexpression of SMS1 or SMS2 in CHO (Chinese-hamster ovary) cells increased TNFα (tumour necrosis factor α)-induced apoptosis [46] . Conversely, siRNA-induced down-regulation of SMS1 or SMS2 in macrophages reduced lipopolysaccharidemediated apoptosis [46] . SMS1 was suggested to play a role in Fas-mediated apoptosis in WR19L/Fas mouse lymphoid cells, in which human Fas was artificially expressed [24] . In these cells, however, unlike S49 AR cells, SMS1 deficiency was not associated with reduced Fas expression at the cell surface, and SMS1 reintroduction facilitated ligand-induced Fas redistribution from non-raft into raft domains and the subsequent DISC formation (typically type II cells). Furthermore, ceramide generation shortly after Fas ligation was suggested to be responsible for an increase in apoptosis induction in SMS1-expressing cells, in line with the concept that small amounts of ceramide generated (by an acid sphingomyelinase) would facilitate clustering of Fas in lipid rafts [47] . However, we (A. H. van der Luit and W. J. van Blitterswijk, unpublished work in S49 cells) and others [22] have not been able to detect rapid ceramide formation after ALP addition or Fas ligation, as opposed to abundant ceramide formation after several hours, in the effector phase of apoptosis [48, 49] . Thus S49 cells differ from WR19L/Fas cells in that SM synthesis relates to Fas expression and stabilization in lipid rafts, rather than to SM-derived ceramide formation in apoptosis induction.
In contrast with the above, there are also reports where SMS expression seems to play an anti-apoptotic role: SMS1 was a suppressor of Bax-mediated cell death in yeast [50] . Furthermore, SMS1 overexpression protected Jurkat cells from photodamageinduced apoptosis [51] , whereas SMS1 knockdown sensitized the cells [52] . Finally, SMS1/2 overexpression was also somewhat protective against apoptosis induction in oligodendrocytes [53] .
Unlike current belief [15, 18, 19] , the SM deficiency in S49 AR cells did not affect cell growth, at least not in normal serumcontaining medium. The cells showed normal phospho-and glyco-lipid profiles, except for decreased SM, which was essentially taken up from the serum. In serum-free (SM-free) medium, growth of S49 AR cells was retarded, but not completely growth arrested.
In conclusion, we found that, in S49 cells, ALP induces apoptosis independently of Fas engagement and that the ALPresistant S49 AR cells are cross-resistant to Fas ligation. We find that the lack of SM synthesis in these resistant cells, although leading to destabilization and reduction of Fas at the cell surface, is not the only factor that causes resistance. Proteasome-dependent reduction of Fas mRNA and protein levels is a major determinant in the resistance to FasL. How this relates to the acquired ALP resistance and SM deficiency in these cells needs to be resolved in future studies. 14 C]choline (1 μCi/ml) for 2 days. Lipid raft fractions (R) and non-raft fractions (NR) were isolated and pooled as indicated. Lipids were extracted and separated by TLC. Indicated are the positions of radioactive phosphatidylcholine (PC), lysophosphatidylcholine (LPC) and the lipid raft marker SM (typically a doublet band; also separately applied in the first lane). Raft fractions from S49 AR and S49 siSMS1 cells were isolated in parallel in exactly the same way.
